Literature DB >> 18787953

Study of association between atrophic gastritis and body mass index: a cross-sectional study in 10,197 Japanese subjects.

Hirotsugu Watabe1, Toru Mitsushima, Mohammad H Derakhshan, Yutaka Yamaji, Makoto Okamoto, Takao Kawabe, Masao Omata, Kenneth E L McColl.   

Abstract

OBJECTIVES: The aim of this study was to elucidate the association between body mass index (BMI) and both Helicobacter pylori and atrophic gastritis.
METHODS: The study involved 10,197 subjects participating in a Japanese mass endoscopic gastric cancer screening program. Atrophic gastritis was assessed by pepsinogen I to II ratio.
RESULTS: In logistic regression models, BMI had an inverse association with atrophic gastritis, with the odds ratios (OR) decreasing progressively to 0.67 (95% confidence interval [CI] 0.57-0.79, P<0.0001) in the highest BMI quintiles (BMI >or=25.66) group compared with the lowest BMI quintiles (BMI <20.97) group. In linear regression models, atrophic gastritis predicted BMI (regression coefficient -0.326, 95% CI -0.469, -0.184, P<0.0001), whereas H. pylori antibody was not a predictor (regression coefficient 0.072, 95% CI -0.053, 0.198, P=0.3).
CONCLUSIONS: A small, inverse association between BMI and atrophic gastritis was found in the general population. In contrast, no association was observed between H. pylori seropositivity and BMI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787953     DOI: 10.1007/s10620-008-0468-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  40 in total

1.  Serum pepsinogens as a screening test of extensive chronic gastritis.

Authors:  K Miki; M Ichinose; A Shimizu; S C Huang; H Oka; C Furihata; T Matsushima; K Takahashi
Journal:  Gastroenterol Jpn       Date:  1987-04

2.  Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study.

Authors:  H Watabe; T Mitsushima; Y Yamaji; M Okamoto; R Wada; T Kokubo; H Doi; H Yoshida; T Kawabe; M Omata
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

3.  Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia.

Authors:  W H Chow; W J Blot; T L Vaughan; H A Risch; M D Gammon; J L Stanford; R Dubrow; J B Schoenberg; S T Mayne; D C Farrow; H Ahsan; A B West; H Rotterdam; S Niwa; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1998-01-21       Impact factor: 13.506

4.  Association between body mass and adenocarcinoma of the esophagus and gastric cardia.

Authors:  J Lagergren; R Bergström; O Nyrén
Journal:  Ann Intern Med       Date:  1999-06-01       Impact factor: 25.391

5.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

6.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

7.  Relationship between pepsinogen I&II and H. pylori infection considered with grade of atrophy and gastroduodenal diseases.

Authors:  Mikio Karita; Ayumi Noriyasu; Eiko Kosako; Satoshi Teramukai; Satoru Matsumoto
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

8.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

9.  Fall in the prevalence of chronic gastritis over 15 years: analysis of outpatient series in Finland from 1977, 1985, and 1992.

Authors:  P Sipponen; T Helske; P Järvinen; H Hyvärinen; K Seppälä; M Siurala
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

Review 10.  The obesity epidemic, metabolic syndrome and future prevention strategies.

Authors:  Philip T James; Neville Rigby; Rachel Leach
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2004-02
View more
  9 in total

1.  Lower serum level of adiponectin is associated with increased risk of endoscopic erosive gastritis.

Authors:  Shunsuke Yamamoto; Kenji Watabe; Shusaku Tsutsui; Shinichi Kiso; Toshimitsu Hamasaki; Motohiko Kato; Yoshihiro Kamada; Yuichi Yoshida; Shinji Kihara; Miyuki Umeda; Aiko Furubayashi; Kazuo Kinoshita; Osamu Kishida; Takashi Fujimoto; Akira Yamada; Yoshifumi Tsukamoto; Norio Hayashi; Yuji Matsuzawa
Journal:  Dig Dis Sci       Date:  2011-03-30       Impact factor: 3.199

2.  The U-shaped association between body mass index and gastric cancer risk in the Helicobacter pylori Biomarker Cohort Consortium: A nested case-control study from eight East Asian cohort studies.

Authors:  Jieun Jang; Tianyi Wang; Hui Cai; Fei Ye; Gwen Murphy; Taichi Shimazu; Philip R Taylor; You-Lin Qiao; Keun-Young Yoo; Sun Ha Jee; Jeongseon Kim; Sheau-Chiann Chen; Christian C Abnet; Shoichiro Tsugane; Wei Zheng; Xiao-Ou Shu; Michael Pawlita; Sue K Park; Meira Epplein
Journal:  Int J Cancer       Date:  2019-12-12       Impact factor: 7.396

3.  Risk factors for atrophic gastritis in the Japanese young and middle-aged: a study using double-contrast upper gastrointestinal barium X-ray radiography.

Authors:  Kimihiko Endo; Hiroshi Nakada; Yoshihito Kadota; Youichi Mizutani; Norihiro Shinkawa; Koji Onoe; Naoki Yoshinaga; Minako Azuma; Toshinori Hirai
Journal:  Jpn J Radiol       Date:  2018-09-27       Impact factor: 2.374

Review 4.  Influence of metabolic syndrome on upper gastrointestinal disease.

Authors:  Masahiro Sogabe; Toshiya Okahisa; Tetsuo Kimura; Koichi Okamoto; Hiroshi Miyamoto; Naoki Muguruma; Tetsuji Takayama
Journal:  Clin J Gastroenterol       Date:  2016-07-02

5.  Impact of Helicobacter pylori Immunoglobulin G Levels and Atrophic Gastritis Status on Risk of Metabolic Syndrome.

Authors:  Atsushi Takeoka; Jun Tayama; Hironori Yamasaki; Masakazu Kobayashi; Sayaka Ogawa; Tatsuo Saigo; Masaki Hayashida; Susumu Shirabe
Journal:  PLoS One       Date:  2016-11-16       Impact factor: 3.240

6.  Cost-Effectiveness Analysis of Helicobacter pylori Diagnostic Methods in Patients with Atrophic Gastritis.

Authors:  Fumio Omata; Takuro Shimbo; Sachiko Ohde; Gautam A Deshpande; Tsuguya Fukui
Journal:  Gastroenterol Res Pract       Date:  2017-02-23       Impact factor: 2.260

7.  Serum pepsinogen II levels are doubled with Helicobacter pylori infection in an asymptomatic population of 40,383 Chinese subjects.

Authors:  Hong Yu; Ying Liu; Shujing Jiang; Yunfeng Zhou; Zheng Guan; Siyuan Dong; Fong-Fong Chu; Chunbo Kang; Qiang Gao
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

8.  Leptin receptor signaling is required for high-fat diet-induced atrophic gastritis in mice.

Authors:  Kyoko Inagaki-Ohara; Shiki Okamoto; Kazuyo Takagi; Kumiko Saito; Seiya Arita; Lijun Tang; Tetsuji Hori; Hiroaki Kataoka; Satoshi Matsumoto; Yasuhiko Minokoshi
Journal:  Nutr Metab (Lond)       Date:  2016-02-02       Impact factor: 4.169

9.  Prevalence and determinants of serological evidence of atrophic gastritis among Arab and Jewish residents of Jerusalem: a cross-sectional study.

Authors:  Dani Cohen; Jeremy D Kark; Khitam Muhsen; Ronit Sinnreich; Dafna Merom; Gany Beer-Davidson; Hisham Nassar
Journal:  BMJ Open       Date:  2019-01-29       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.